Gennao Bio logo

Gennao Bio jobs and careers

Hopewell, NJ, United States

About Gennao Bio

Gennao Bio is a privately held genetic medicines company developing first-in-class targeted nucleic acid therapeutics utilizing a proprietary gene monoclonal antibody (GMAB) platform technology.

Founded in 2020 by Bruce Turner, Dr. Peter Glazer, MD, PhD, Elias Quijano and Stephen Squinto.

Founded
2020
Employees
11 to 50
Total funding
$41M
Headquarters
Hopewell

Leadership

The top of Gennao Bio's org chart, with how many people report into each leader.

CDPhoto of Chris Duke

Chris Duke

Interim CEO

1 report

JHPhoto of John Heyburn

John Heyburn

Senior Vice President, Program Management

Board

BC

Bradley Campbell

Director

EQPhoto of Elias Quijano

Elias Quijano

Co-Founder

PGPhoto of Peter Glazer

Peter Glazer

Co-Founder

JH

Julie Hambleton

Director

PT

Peter Thompson

Director